A Canadian study monitored more than 1,400 women living with HIV. Nearly 30% of women diagnosed with HIV did not achieve viral suppression. Some groups of women had greater challenges with adherence and staying in care. Studies of people who are starting HIV treatment (ART) have found that when ART is taken as directed for […]
Canadian study examines why some women fall out of the HIV care cascade Read More »
Researchers compared substance use between HIV-positive and HIV-negative women Women living with HIV were more likely to report use of most substances except alcohol Study authors call for harm reduction programs tailored to women living with HIV Studies have found that substance use is relatively common among some populations at high risk for and who
Comparing substance use patterns among women in Canada Read More »
Relationships among gay, bisexual and other men who have sex with men are diverse, displaying a range of behaviours and preferences about sex and sexual pleasure that should be further explored in research.
Condomless anal sex among gbMSM with partners met online is associated with a variety of interpersonal factors to be considered in health interventions.
Cigarette smoking remains a serious public health concern and gbMSM are more likely to smoke than the general population.
Evidence from British Columbia and elsewhere has demonstrated the expansion of access to antiretroviral HIV treatment (ART) can result in population-level reductions in HIV incidence. This is the concept behind the made-in-BC Treatment as Prevention strategy, or TasP, which aims to expand early HIV testing and treatment to improve patients’ health and curb the spread
HIV risk reduction strategies are evolving with important implications for HIV research to be further investigated.
There are still a number of barriers to be addressed in the uptake of HIV prevention methods and technologies.
Biomedical research demonstrating the benefits of taking HIV treatment to prevent HIV transmission (known as treatment as prevention, or TasP) has developed substantially in recent years. We are now able to say with confidence that an HIV-positive person who takes antiretroviral treatment (ART) and maintains an undetectable viral load cannot pass HIV to a sexual
A Canadian study found that a patient’s age was a factor in HIV viral rebound after suppression with treatment, with younger adults experiencing lower prevalence of viral suppression and shorter time to viral rebound than older adults. “There is an age effect,” principle investigator Robert Hogg, MSc, PhD, British Columbia Centre for Excellence in HIV/AIDS,
Younger Adults with HIV Experience Shorter Times to Viral Rebound Read More »
